Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:02:32 UTC
Update Date2022-09-22 18:34:22 UTC
HMDB IDHMDB0028805
Secondary Accession Numbers
  • HMDB28805
Metabolite Identification
Common NameGlutaminylproline
DescriptionGlutaminylproline, also known as Q-p dipeptide or GLN-pro, belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Glutaminylproline has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make glutaminylproline a potential biomarker for the consumption of these foods. Based on a literature review very few articles have been published on Glutaminylproline.
Structure
Data?1582753342
Synonyms
ValueSource
GLN-ProHMDB
L-Glutaminyl-L-prolineHMDB
Glutaminyl-prolineHMDB
Glutamine proline dipeptideHMDB
Glutamine-proline dipeptideHMDB
Q-p DipeptideHMDB
QP DipeptideHMDB
L-GLN-L-ProHMDB
(2S)-1-[(2S)-2-Amino-4-(C-hydroxycarbonimidoyl)butanoyl]pyrrolidine-2-carboxylateHMDB
GlutaminylprolineHMDB
Chemical FormulaC10H17N3O4
Average Molecular Weight243.263
Monoisotopic Molecular Weight243.121906039
IUPAC Name(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid
Traditional Name(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid
CAS Registry Number139370-58-4
SMILES
N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O
InChI Identifier
InChI=1S/C10H17N3O4/c11-6(3-4-8(12)14)9(15)13-5-1-2-7(13)10(16)17/h6-7H,1-5,11H2,(H2,12,14)(H,16,17)/t6-,7-/m0/s1
InChI KeyNJMYZEJORPYOTO-BQBZGAKWSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • N-acyl-alpha amino acid or derivatives
  • Proline or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-l-alpha-amino acid
  • Alpha-amino acid amide
  • Alpha-amino acid or derivatives
  • N-acylpyrrolidine
  • Pyrrolidine carboxylic acid
  • Pyrrolidine carboxylic acid or derivatives
  • Fatty acyl
  • Fatty amide
  • Tertiary carboxylic acid amide
  • Pyrrolidine
  • Amino acid
  • Primary carboxylic acid amide
  • Amino acid or derivatives
  • Carboxamide group
  • Carboxylic acid
  • Azacycle
  • Monocarboxylic acid or derivatives
  • Organoheterocyclic compound
  • Organic oxygen compound
  • Primary aliphatic amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Carbonyl group
  • Organic oxide
  • Amine
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Aliphatic heteromonocyclic compound
Molecular FrameworkAliphatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-4.27Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility21.9 g/LALOGPS
logP-3ALOGPS
logP-4.3ChemAxon
logS-1ALOGPS
pKa (Strongest Acidic)3.58ChemAxon
pKa (Strongest Basic)8.22ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area126.72 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity58.1 m³·mol⁻¹ChemAxon
Polarizability23.99 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+159.76630932474
DeepCCS[M-H]-157.40830932474
DeepCCS[M-2H]-190.29430932474
DeepCCS[M+Na]+165.85930932474
AllCCS[M+H]+152.632859911
AllCCS[M+H-H2O]+149.232859911
AllCCS[M+NH4]+155.732859911
AllCCS[M+Na]+156.632859911
AllCCS[M-H]-154.332859911
AllCCS[M+Na-2H]-154.432859911
AllCCS[M+HCOO]-154.632859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.1.72 minutes32390414
Predicted by Siyang on May 30, 20229.0375 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20229.24 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid373.5 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid474.0 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid229.4 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid72.2 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid161.5 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid51.1 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid262.3 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid257.4 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)881.0 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid555.0 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid45.2 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid686.4 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid177.8 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid214.0 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate747.9 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA610.7 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water366.2 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
GlutaminylprolineN[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O3101.0Standard polar33892256
GlutaminylprolineN[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O2377.0Standard non polar33892256
GlutaminylprolineN[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O2486.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Glutaminylproline,1TMS,isomer #1C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O2353.4Semi standard non polar33892256
Glutaminylproline,1TMS,isomer #2C[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O2388.3Semi standard non polar33892256
Glutaminylproline,1TMS,isomer #3C[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O2368.8Semi standard non polar33892256
Glutaminylproline,2TMS,isomer #1C[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2386.1Semi standard non polar33892256
Glutaminylproline,2TMS,isomer #1C[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2308.6Standard non polar33892256
Glutaminylproline,2TMS,isomer #2C[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2378.5Semi standard non polar33892256
Glutaminylproline,2TMS,isomer #2C[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2379.3Standard non polar33892256
Glutaminylproline,2TMS,isomer #3C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2423.5Semi standard non polar33892256
Glutaminylproline,2TMS,isomer #3C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2430.9Standard non polar33892256
Glutaminylproline,2TMS,isomer #4C[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2471.7Semi standard non polar33892256
Glutaminylproline,2TMS,isomer #4C[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2374.2Standard non polar33892256
Glutaminylproline,2TMS,isomer #5C[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2441.6Semi standard non polar33892256
Glutaminylproline,2TMS,isomer #5C[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C2420.0Standard non polar33892256
Glutaminylproline,3TMS,isomer #1C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2428.0Semi standard non polar33892256
Glutaminylproline,3TMS,isomer #1C[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2474.9Standard non polar33892256
Glutaminylproline,3TMS,isomer #2C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C)[Si](C)(C)C2513.6Semi standard non polar33892256
Glutaminylproline,3TMS,isomer #2C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C)[Si](C)(C)C2428.0Standard non polar33892256
Glutaminylproline,3TMS,isomer #3C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C)[Si](C)(C)C2446.9Semi standard non polar33892256
Glutaminylproline,3TMS,isomer #3C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C)[Si](C)(C)C2470.2Standard non polar33892256
Glutaminylproline,3TMS,isomer #4C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2491.6Semi standard non polar33892256
Glutaminylproline,3TMS,isomer #4C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2513.9Standard non polar33892256
Glutaminylproline,3TMS,isomer #5C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C2540.0Semi standard non polar33892256
Glutaminylproline,3TMS,isomer #5C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C2531.6Standard non polar33892256
Glutaminylproline,4TMS,isomer #1C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2511.0Semi standard non polar33892256
Glutaminylproline,4TMS,isomer #1C[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C2549.2Standard non polar33892256
Glutaminylproline,4TMS,isomer #2C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2572.4Semi standard non polar33892256
Glutaminylproline,4TMS,isomer #2C[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2558.6Standard non polar33892256
Glutaminylproline,4TMS,isomer #3C[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2655.7Semi standard non polar33892256
Glutaminylproline,4TMS,isomer #3C[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2622.6Standard non polar33892256
Glutaminylproline,5TMS,isomer #1C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2694.6Semi standard non polar33892256
Glutaminylproline,5TMS,isomer #1C[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C)[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C2642.3Standard non polar33892256
Glutaminylproline,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O2602.3Semi standard non polar33892256
Glutaminylproline,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O2639.5Semi standard non polar33892256
Glutaminylproline,1TBDMS,isomer #3CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O2637.6Semi standard non polar33892256
Glutaminylproline,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2857.9Semi standard non polar33892256
Glutaminylproline,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2713.8Standard non polar33892256
Glutaminylproline,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2841.2Semi standard non polar33892256
Glutaminylproline,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2766.7Standard non polar33892256
Glutaminylproline,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2917.9Semi standard non polar33892256
Glutaminylproline,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O2792.8Standard non polar33892256
Glutaminylproline,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2925.1Semi standard non polar33892256
Glutaminylproline,2TBDMS,isomer #4CC(C)(C)[Si](C)(C)N([C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2797.9Standard non polar33892256
Glutaminylproline,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2915.1Semi standard non polar33892256
Glutaminylproline,2TBDMS,isomer #5CC(C)(C)[Si](C)(C)N(C(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)O)[Si](C)(C)C(C)(C)C2839.2Standard non polar33892256
Glutaminylproline,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C3114.1Semi standard non polar33892256
Glutaminylproline,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)NC(=O)CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C2991.0Standard non polar33892256
Glutaminylproline,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3157.3Semi standard non polar33892256
Glutaminylproline,3TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2992.0Standard non polar33892256
Glutaminylproline,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3107.4Semi standard non polar33892256
Glutaminylproline,3TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3040.3Standard non polar33892256
Glutaminylproline,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O3186.4Semi standard non polar33892256
Glutaminylproline,3TBDMS,isomer #4CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O3074.6Standard non polar33892256
Glutaminylproline,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3219.8Semi standard non polar33892256
Glutaminylproline,3TBDMS,isomer #5CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3065.1Standard non polar33892256
Glutaminylproline,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C3390.9Semi standard non polar33892256
Glutaminylproline,4TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C3233.6Standard non polar33892256
Glutaminylproline,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3446.7Semi standard non polar33892256
Glutaminylproline,4TBDMS,isomer #2CC(C)(C)[Si](C)(C)NC(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3222.3Standard non polar33892256
Glutaminylproline,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3521.9Semi standard non polar33892256
Glutaminylproline,4TBDMS,isomer #3CC(C)(C)[Si](C)(C)N(C(=O)CC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3331.5Standard non polar33892256
Glutaminylproline,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3727.0Semi standard non polar33892256
Glutaminylproline,5TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3449.3Standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Glutaminylproline GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 10V, Positive-QTOFsplash10-004i-0390000000-352cc3006c7cf857d0392018-11-27Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 20V, Positive-QTOFsplash10-003r-7980000000-3b7a1266324df9103b4e2018-11-27Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 40V, Positive-QTOFsplash10-0q30-9100000000-187c618d99ad73d4737a2018-11-27Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 10V, Positive-QTOFsplash10-002f-0190000000-25dafb19ee955d7d1a942021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 20V, Positive-QTOFsplash10-001i-9730000000-fb9c6e43453b13889ec22021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 40V, Positive-QTOFsplash10-05a9-9000000000-bf90fa924f6062b559fe2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 10V, Negative-QTOFsplash10-0006-0190000000-856ae8ca7e40d0e64f0e2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 20V, Negative-QTOFsplash10-03di-4910000000-3c553fb2974702dc02c02021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Glutaminylproline 40V, Negative-QTOFsplash10-03dj-9500000000-f30736a1fcefac9308482021-10-11Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-29Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Feces
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothCrohns disease details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothIron deficiency details
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedCancer patients undergoing total body irradiation details
Associated Disorders and Diseases
Disease References
Crohn's disease
  1. Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
Iron deficiency
  1. Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB111851
KNApSAcK IDNot Available
Chemspider ID9911368
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound11736661
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Sucov HM, Benson S, Robinson JJ, Britten RJ, Wilt F, Davidson EH: A lineage-specific gene encoding a major matrix protein of the sea urchin embryo spicule. II. Structure of the gene and derived sequence of the protein. Dev Biol. 1987 Apr;120(2):507-19. [PubMed:3030858 ]
  2. Lee T, Clavel T, Smirnov K, Schmidt A, Lagkouvardos I, Walker A, Lucio M, Michalke B, Schmitt-Kopplin P, Fedorak R, Haller D: Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut. 2017 May;66(5):863-871. doi: 10.1136/gutjnl-2015-309940. Epub 2016 Feb 4. [PubMed:26848182 ]